Stanford researchers have developed tissue-based profiling by deep sequencing for detection of Minimal Residual Disease (MRD) by tracking patient-specific tumor mutations in post-chemotherapy tissue samples, enabling a highly sensitive, molecular-level assessment of residual c
Stanford researchers have developed an innovative ureteral stent (UreStent) which is designed to reduce stent-related complications by incorporating a distal tip with collapsible tube and a flexible retention cone to prevent urine reflux and bladder irritation, ensuring optima
Researchers at Stanford University have created a novel mitral valve annuloplasty ring that can be adjusted in size off-bypass in response to regurgitation.
Using their novel fabrication process, Stanford researchers have produced the world's first practical titanium-sapphire laser on a chip, transforming a once-exclusive tabletop technology to the microscale.
Researchers at Stanford have developed fusion proteins, containing ACE2 domain linked to a fragment of non-neutralizing anti-SARS-CoV-2 spike protein antibody, with a greater breadth of protection than previously described similar fusion proteins.
Researchers at Stanford have developed fully genetically-encodable lysosome-targeting chimeras which allow for the targeted delivery of various proteins into receiver cells.
Stanford researchers have developed a novel fabrication method of high thermal conductivity 3D heat spreaders for semiconductor devices. Self-heating in the channel of semiconductor devices degrades device performance and shortens device lifetimes.
Stanford researchers have developed an in silico method, JEEPERS, that corrects DNA methylation errors at jagged-ends, improving cfDNA methylation profiling for early cancer detection and tissue-of-origin classification.
Theranostics represents a paradigm shift in cancer treatment, offering a more personalized and molecular approach to cancer diagnosis and treatment with striking efficacy and low toxicity.